Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Polyethylene glycol 3350 Lax-a-day Laxative 2009/03/09
Polyethylene glycol 3350 Pegalax Laxative
Polidocanol Varithena Sclerosing agent 2015/08/04
Pneumococcal 13-valent conjugate vaccine Prevnar 13 Vaccine 2010/03/17
Plerixafor Mozobil Hematopoietic agent 2012/01/26
Pirfenidone Esbriet Anti-fibrotic agent 2013/01
Phosphate Effervescent Phosphate Sandoz 2017/01/01
Pertuzumab Perjeta Antineoplastic agent 2013/04/23
Perampanel Fycompa Anticonvulsant 2013/09/04
Pazopanib Votrient Antineoplastic agent 2011/08/25
Patiromer Veltassa Potassium binder 2020/03/09
Pasireotide Signifor Synthetic analogue of somatostatin 2013/11/26
Pancrelipase Cotazym ECS 4 & Cotazym 65B Pancreatic enzymes 2012/02/06
Palonosetron + netupitant Akynzeo Antiemetic 2017/12/04
Palonosetron Aloxi 5TH3 antagonist 2012/03/14
Paliperidone palmitate Invega Sustenna Antipsychotic agent 2010/07/28
Paliperidone Invega Antipsychotic agent 2007/10/02
Oxycodone + naloxone Targin opioid 2009/12/30
Oxycodone OxyContin Narcotic 2012/02/29
Oxycodone OxyNEO Narcotic 2012/01/01
Oxybutynin Gelnique Anticholinergic / Antispasmodic 2012/03/05
Oxybutynin Uromax Urinary Antispasmodic
Ondansetron Ondissolve ODF Antiemetic 2013/04
Onasemnogene Zolgensma Cellular and gene therapy 2021/02/04
Olopatadine Pataday Anti-allergy agent 2011/04/14
Olmesartan + hydrochlorothiazide Olmetec Plus Antihypertensive agent 2009/02
Olmesartan Olmetec Antihypertensive agent 2009/02
Ofatumumab Arzerra Antineoplastic agent 2012/03/09
Ofatumumab Kesimpta Immunomudulator 2021/04/08
Norgestrel + ethinyl estradiol Ovral Oral contraceptive
Norethindrone acetate + ethinyl estradiol femHRT estrogen-progesterone combination 2012/10/09
Niraparib Zejula Antineoplastic agent 2020/01/09
Nebivolol Bystolic Beta-blocker, cardioselective 2013/04
Naproxen + Esomeprazole Vimovo NSAID + PPI 2011/01/14
Naltrexone + bupropion Contrave Anorexigenic agents 2018/02/13
Naloxegol Movantik Miscellaneous GI drug 2015/08/27
Syndicate content